临床试验的研究持续时间预测与时间到事件的终点,考虑到异质人口的预测
Hong Zhang1, Jie Pu1, Shibing Deng1
1Global Biometrics and Data Management, Pfizer Inc., New York, USA.
Journal of biopharmaceutical statistics
|April 20, 2025
概括
预测临床试验持续时间对于精准医学至关重要. 本研究引入了一个使用混合物分布的框架,以准确估计生物标志物引导的试验长度,考虑到人口异质性和关键参数.
科学领域:
- 生物医学科学 生物医学科学
- 临床试验设计 临床试验设计
- 药物基因组学 药物基因组学
背景情况:
- 生物标志物指导的临床试验是精准医学的核心,以优化疾病管理.
- 与传统设计相比,量化效率的提高,特别是试验持续时间,仍然是一个挑战.
- 由于限制较少,通用设计的入学率可能会更快.
研究的目的:
- 为准确预测生物标志物指导临床试验持续时间制定一个一般框架.
- 量化比较生物标志物指导与全方位试验设计的效率.
- 确定影响异质群体试验持续时间的关键参数.
主要方法:
- 一个新的框架,利用混合分布来建模异质种群.
- 进行了广泛的模拟,以评估人口异质性和生物标志物动态的影响.
- 经验验证使用对两项公开可用的临床试验的重新评估.
主要成果:
- 确定了影响研究持续时间的有影响力的参数,包括中位生存时间,入学率,生物标志物流行率和效果大小.
- 拟议的框架准确地预测了试验持续时间,并通过真实世界的数据进行了验证.
- 证明了预测框架在临床试验规划中的实际实用性.
结论:
- 开发的框架提供了一种可靠的方法来预测生物标志物引导的临床试验持续时间.
- 准确的持续时间预测有助于优化资源分配和准确医学中的试验管理.
- 了解人口异质性和生物标志物特征的相互作用是有效试验设计的关键.
更多相关视频
相关概念视频
Introduction To Survival Analysis
115
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
115
Comparing the Survival Analysis of Two or More Groups
85
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
85
Truncation in Survival Analysis
124
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
124
Actuarial Approach
39
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
39
Assumptions of Survival Analysis
57
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
57
Kaplan-Meier Approach
55
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
55


